as part of a multicenter trial of etidronate disodium for control of hypercalcemia in patients with malignancies , patients achieving normocalcemia within seven days after starting intravenous therapy with etidronate disodium plus saline were enrolled into a double-blind , placebo-controlled trial of oral etidronate disodium to maintain normocalcemia .
C0037507
etidronate disodium
C0086268
etidronate